These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 20466735

  • 1. Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.
    Barekati Z, Radpour R, Kohler C, Zhang B, Toniolo P, Lenner P, Lv Q, Zheng H, Zhong XY.
    Hum Mol Genet; 2010 Aug 01; 19(15):2936-46. PubMed ID: 20466735
    [Abstract] [Full Text] [Related]

  • 2. Number of somatic mutations in the mitochondrial D-loop region indicates poor prognosis in breast cancer, independent of TP53 mutation.
    Kuo SJ, Chen M, Ma GC, Chen ST, Chang SP, Lin WY, Chen YC, Lee TH, Lin TT, Liu CS.
    Cancer Genet Cytogenet; 2010 Sep 01; 201(2):94-101. PubMed ID: 20682393
    [Abstract] [Full Text] [Related]

  • 3. Wip1 over-expression correlated with TP53/p14(ARF) pathway disruption in human astrocytomas.
    Wang P, Rao J, Yang H, Zhao H, Yang L.
    J Surg Oncol; 2011 Nov 01; 104(6):679-84. PubMed ID: 21695702
    [Abstract] [Full Text] [Related]

  • 4. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T.
    Clin Cancer Res; 2003 Oct 15; 9(13):4884-90. PubMed ID: 14581362
    [Abstract] [Full Text] [Related]

  • 5. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.
    Kang MY, Lee BB, Ji YI, Jung EH, Chun HK, Song SY, Park SE, Park J, Kim DH.
    Cancer; 2008 Apr 15; 112(8):1699-707. PubMed ID: 18327804
    [Abstract] [Full Text] [Related]

  • 6. Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
    van den Broek AJ, Broeks A, Horlings HM, Canisius SV, Braaf LM, Langerød A, Van't Veer LJ, Schmidt MK.
    Breast Cancer Res Treat; 2011 Nov 15; 130(2):599-608. PubMed ID: 21667122
    [Abstract] [Full Text] [Related]

  • 7. Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter hypermethylation.
    Sadeq V, Isar N, Manoochehr T.
    Med Oncol; 2011 Jun 15; 28(2):420-3. PubMed ID: 20237868
    [Abstract] [Full Text] [Related]

  • 8. CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer.
    Chrisanthar R, Knappskog S, Løkkevik E, Anker G, Østenstad B, Lundgren S, Berge EO, Risberg T, Mjaaland I, Maehle L, Engebretsen LF, Lillehaug JR, Lønning PE.
    PLoS One; 2008 Aug 26; 3(8):e3062. PubMed ID: 18725978
    [Abstract] [Full Text] [Related]

  • 9. Genetic and methylation status of CDKN2A (p14ARF/p16INK4A) and TP53 genes in recurrent respiratory papillomatosis.
    Chantre-Justino M, Gonçalves da Veiga Pires I, Cardoso Figueiredo M, Dos Santos Moreira A, Alves G, Faria Ornellas MH.
    Hum Pathol; 2022 Jan 26; 119():94-104. PubMed ID: 34826422
    [Abstract] [Full Text] [Related]

  • 10. Epigenetic and genetic burden measures are associated with tumor characteristics in invasive breast carcinoma.
    O'Sullivan DE, Johnson KC, Skinner L, Koestler DC, Christensen BC.
    Epigenetics; 2016 May 03; 11(5):344-53. PubMed ID: 27070496
    [Abstract] [Full Text] [Related]

  • 11. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
    Sharma G, Mirza S, Prasad CP, Srivastava A, Gupta SD, Ralhan R.
    Life Sci; 2007 Apr 24; 80(20):1873-81. PubMed ID: 17383681
    [Abstract] [Full Text] [Related]

  • 12. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
    Molnár B, Galamb O, Péterfia B, Wichmann B, Csabai I, Bodor A, Kalmár A, Szigeti KA, Barták BK, Nagy ZB, Valcz G, Patai ÁV, Igaz P, Tulassay Z.
    BMC Cancer; 2018 Jun 27; 18(1):695. PubMed ID: 29945573
    [Abstract] [Full Text] [Related]

  • 13. The novel TP53 3'-end methylation pattern associated with its expression would be a potential biomarker for breast cancer detection.
    Zeng F, Heng J, Guo X, Wang Y, Wu W, Tang L, Chen M, Wang S, Deng H, Wang J.
    Breast Cancer Res Treat; 2020 Feb 27; 180(1):237-245. PubMed ID: 31983017
    [Abstract] [Full Text] [Related]

  • 14. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
    Jarmalaite S, Kannio A, Anttila S, Lazutka JR, Husgafvel-Pursiainen K.
    Int J Cancer; 2003 Oct 10; 106(6):913-8. PubMed ID: 12918069
    [Abstract] [Full Text] [Related]

  • 15. TP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses.
    Perrone F, Oggionni M, Birindelli S, Suardi S, Tabano S, Romano R, Moiraghi ML, Bimbi G, Quattrone P, Cantu G, Pierotti MA, Licitra L, Pilotti S.
    Int J Cancer; 2003 Jun 10; 105(2):196-203. PubMed ID: 12673679
    [Abstract] [Full Text] [Related]

  • 16. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.
    Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835
    [Abstract] [Full Text] [Related]

  • 17. Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma.
    Guerra F, Kurelac I, Cormio A, Zuntini R, Amato LB, Ceccarelli C, Santini D, Cormio G, Fracasso F, Selvaggi L, Resta L, Attimonelli M, Gadaleta MN, Gasparre G.
    Hum Mol Genet; 2011 Jun 15; 20(12):2394-405. PubMed ID: 21470976
    [Abstract] [Full Text] [Related]

  • 18. Assessment of Promoter Hypermethylation and Expression Profile of P14ARF and MDM2 Genes in Patients With Pterygium.
    Arish M, Kordi-Tamandani DM, Sangterash MH, Poyandeh R.
    Eye Contact Lens; 2016 Jan 15; 42(1):e4-7. PubMed ID: 26020483
    [Abstract] [Full Text] [Related]

  • 19. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.
    Invest Ophthalmol Vis Sci; 2002 Sep 15; 43(9):2845-51. PubMed ID: 12202501
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.